Anebulo Pharmaceuticals (ANEB) Prepaid Assets (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Prepaid Assets of $60700.0 for Q4 2025, down 65.96% year-over-year from $178345.0 in Q4 2024, and down 64.46% quarter-over-quarter from $170771.0 in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Prepaid Assets (2021 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Prepaid Assets for 5 consecutive years, with $60700.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets fell 65.96% year-over-year to $60700.0; the TTM figure through Dec 2025 stood at $60700.0 (down 65.96% YoY), while the FY2025 annual figure was $35002.0, down 18.68% from the prior year.
- Prepaid Assets retreated to $60700.0 in Q4 2025 per ANEB's latest filing, from $170771.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.7 million in Q2 2021 and bottomed at $15040.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $374515.5 across 5 years, with a median of $271013.0 in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets slumped 98.22% — and 2024, when it jumped 1085.8%.
- Anebulo Pharmaceuticals' Prepaid Assets stood at $458708.0 in 2021, then climbed by 16.18% to $532906.0 in 2022, then plunged by 97.18% to $15040.0 in 2023, then surged by 1085.8% to $178345.0 in 2024, then tumbled by 65.96% to $60700.0 in 2025.
- Business Quant data shows ANEB's Prepaid Assets at $60700.0 in Q4 2025, $170771.0 in Q3 2025, and $35002.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60,700.00 |
| Sep 30, 2025 | 170,771.00 |
| Jun 30, 2025 | 35,002.00 |
| Mar 31, 2025 | 528,034.00 |
| Dec 31, 2024 | 178,345.00 |
| Sep 30, 2024 | 312,940.00 |
| Jun 30, 2024 | 43,040.00 |
| Mar 31, 2024 | 223,676.00 |
| Dec 31, 2023 | 15,040.00 |
| Sep 30, 2023 | 274,225.00 |
| Jun 30, 2023 | 30,998.00 |
| Mar 31, 2023 | 267,801.00 |
| Dec 31, 2022 | 532,906.00 |
| Sep 30, 2022 | 601,668.00 |
| Jun 30, 2022 | 29,752.00 |
| Mar 31, 2022 | 700,740.00 |
| Dec 31, 2021 | 458,708.00 |
| Sep 30, 2021 | 766,456.00 |
| Jun 30, 2021 | 1.67 Mn |
| Mar 31, 2021 | 591,662.00 |